Inventor
LIGNEAU XAVIER
FR20 patents
⚠️ This page may combine multiple inventors who share the name “LIGNEAU XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOPROJET SOC CIV
9 patentsUS9029357B2May 12, 2015
Benzazole derivatives as histamine H4 receptor ligands
BIOPROJET SOC CIV4 citations71
US12134608B2Nov 5, 2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands
BIOPROJET SOC CIV0 citations61
US11306069B2Apr 19, 2022
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands
BIOPROJET SOC CIV0 citations61
US8354430B2Jan 15, 2013
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
BIOPROJET SOC CIV3 citations60
US12059416B2Aug 13, 2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
BIOPROJET SOC CIV0 citations59
US11229632B2Jan 25, 2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
BIOPROJET SOC CIV0 citations59
US10952987B2Mar 23, 2021
Combination of adrenalin with an antidepressant for use in the treatment of shocks
BIOPROJET SOC CIV0 citations58
US9242959B2Jan 26, 2016
(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
BIOPROJET SOC CIV0 citations40
US8017646B2Sep 13, 2011
Histamine H3-receptor ligands and their therapeutic application
BIOPROJET SOC CIV0 citations40
ILE BIOPROJET SOC CIV
2 patentsUS7138413B1Nov 21, 2006
Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
ILE BIOPROJET SOC CIV19 citations89
US7910605B2Mar 22, 2011
Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
ILE BIOPROJET SOC CIV8 citations81